ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: Stand Up To Cancer Canada to Fund Two Dream Teams

October 17, 2014

NIH Bias Against Young Investigators Threatens To “Deprime The Pump,” Zerhouni Says.

February 15, 2008

Cancer Death Rates Declined 2.1 Percent Per Year.

October 19, 2007

$20 Million In Construction Funds Approved

April 2, 1976

CCOP Review Completed; 72 Applications Submitted, 23 More For Minority CCOP

December 1, 1989

Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure?

September 2, 1977